Research interests include Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Epigenetics and DNA Methylation, and Pancreatic function and diabetes.
Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma
Journal of Clinical Oncology2018cited by 161position: middledoi
Selinexor and Low Dose Dexamethasone (Sd) in Patients with Lenalidomide, Pomalidomide, Bortezomib, Carfilzomib and Anti-CD38 Ab Refractory Multiple Myeloma (MM): STORM Study